HOB Biotech Group Corp.,Ltd Stock

Equities

688656

CNE100004C37

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
23.65 CNY +1.98% Intraday chart for HOB Biotech Group Corp.,Ltd +12.09% -31.96%
Sales 2021 318M 43.85M Sales 2022 320M 44.22M Capitalization 2.11B 292M
Net income 2021 86M 11.87M Net income 2022 41M 5.66M EV / Sales 2021 11.2 x
Net cash position 2021 424M 58.52M Net cash position 2022 224M 30.86M EV / Sales 2022 5.9 x
P/E ratio 2021
45 x
P/E ratio 2022
50.8 x
Employees 488
Yield 2021
0.84%
Yield 2022
0.89%
Free-Float 20.83%
More Fundamentals * Assessed data
Dynamic Chart
HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares. CI
HOB Biotech Group Corp.,Ltd authorizes a Buyback Plan. CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2024. CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
HOB Biotech Inks Deal With Spain’s Inmunotek to Distribute Allergy Treatment in China MT
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange Composite Index CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange A Share Index CI
More news
1 day+1.98%
1 week+12.09%
Current month-9.84%
1 month-11.02%
3 months-15.78%
6 months-37.15%
Current year-31.96%
More quotes
1 week
22.07
Extreme 22.07
23.91
1 month
21.07
Extreme 21.07
27.05
Current year
17.93
Extreme 17.93
35.75
1 year
17.93
Extreme 17.93
41.58
3 years
17.93
Extreme 17.93
92.49
5 years
17.93
Extreme 17.93
102.98
10 years
17.93
Extreme 17.93
102.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 06-12-31
Director of Finance/CFO 44 23-07-06
Chairman 46 15-03-31
Members of the board TitleAgeSince
Chief Executive Officer 61 06-12-31
Chairman 46 15-03-31
Director/Board Member 60 13-09-30
More insiders
Date Price Change Volume
24-04-24 23.65 +1.98% 368,224
24-04-23 23.19 +0.22% 475,302
24-04-22 23.14 +2.89% 385,745
24-04-19 22.49 -1.01% 263,207
24-04-18 22.72 +1.70% 388,113

End-of-day quote Shanghai S.E., April 23, 2024

More quotes
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 688656 Stock